Medicare Part D coverage · 2 · RxCUI 2055650
2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro]
Per the CMS 2026 Part D formulary file, 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] is covered by 340 Medicare Part D plans (6.7% of enrollable products), averaging Tier 4.7, with prior authorization required on 93.5% of covering formularies.
- 6.7%
- Plan coverage
- 340
- Plans covering
- T4.7
- Avg tier
- 93.5%
- Prior auth required
What the CMS Formulary Data Shows for 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro]
Per the CMS 2026 Part D formulary file, 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] (RxNorm concept RXCUI 2055650, generic name 2) appears on 31 distinct formulary files spanning 340 Medicare Part D plan offerings - 6.7% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 4.7.
Real-world access to 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] depends on utilization management as much as tier placement: 93.5% of covering formularies require prior authorization. 0% require step therapy. 71% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 27 Part D beneficiaries filled 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] in 2023, with total plan-and-beneficiary spending of $5,832,614 and an average per-beneficiary annual cost of $216,022.73. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] today.
Coverage Details
- Formularies covering
- 31
- Plans covering
- 340
- Coverage rate
- 6.7%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 5, Specialty
Restrictions
- Prior authorization required
- 93.5% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 71% of formularies
2023 Medicare Spending
- Beneficiaries
- 27
- Total spending
- $5,832,614
- Avg per beneficiary
- $216,022.73
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | Yes | $4.80 | FL |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Arizona | T1 | Yes | $17.00 | AZ |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| PHP (HMO C-snp) | Aids Healthcare Foundation | T4 | Yes | $0 | CA |
| VNS Health Total (HMO D-SNP) | VNS Choice | T4 | Yes | $0 | NY |
| Leon MediExtra (HMO) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| Leon MediDual (HMO D-SNP) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| Leon MediMore (HMO) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| Leon MediMax (HMO D-SNP) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| VNS Health EasyCare Plus (HMO D-SNP) | VNS Choice | T4 | Yes | $51.60 | NY |
| HealthSun HealthAdvantage Plan (HMO) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun MediMax (HMO) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun HealthAdvantage Plan (HMO) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun HealthAdvantage Plan (HMO) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun MediSun Plus (HMO D-SNP) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun HealthAdvantage Plus (HMO) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun HealthAdvantage Plus (HMO) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun MediSun Extra (HMO D-SNP) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun HealthAdvantage Plus (HMO) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun VitalCare (HMO C-SNP) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
Show the next 30 plans
| HealthSun VitalCare (HMO C-SNP) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun MediSun Full Dual Plus (HMO D-SNP) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| HealthSun MediSun Full Dual Extra (HMO D-SNP) | Healthsun Health Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Complete (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Complete (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Level (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Level (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Level (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Level (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Complete (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Level (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Complete (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Extra (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Extra Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply More Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Complete Platinum (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Level Platinum (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Extra Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Level Platinum (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Extra Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Level Platinum (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Extra Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply More Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Simply Complete Platinum (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] covered by Medicare Part D?
Yes, 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] is covered by 340 Medicare Part D plans (6.7% of all Part D formularies).
What tier is 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] on Medicare Part D plans?
2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] averages Tier 4.7 across Part D plans, ranging from Tier 1 to Tier 6.
Does 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] require prior authorization?
93.5% of Part D formularies require prior authorization for 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro]. Step therapy: 0%. Quantity limits: 71%.
How much does Medicare spend on 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro]?
In 2023, total Medicare Part D spending on 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] was $5,832,614, covering 27 beneficiaries. The average spend per beneficiary was $216,022.73.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 0.2 ML adalimumab-adbm 50 MG/ML Prefilled Syringe T4.7
- 0.4 ML adalimumab-adbm 50 MG/ML Prefilled Syringe T4.7
- 0.8 ML adalimumab-adbm 50 MG/ML Prefilled Syringe T4.7
- 0.1 ML adalimumab-adaz 100 MG/ML Prefilled Syringe T4.7
- 0.2 ML adalimumab-adaz 100 MG/ML Prefilled Syringe T4.7
- 0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector T4.7
Similar prior-authorization rate
- {84 (amoxicillin 500 MG Oral Capsule) / 28 (vonoprazan 20 MG Oral Tablet) } Pack [Voquezna 14 Day DualPak 20;500] 93.5% PA
- levacetylleucine 1000 MG Granules for Oral Suspension [Aqneursa] 93.5% PA
- tesamorelin 11.6 MG Injection [Egrifta] 93.5% PA
- deferasirox 90 MG Oral Tablet 93.7% PA
- vonoprazan 10 MG Oral Tablet [Voquezna] 93.3% PA
- {4 (ozanimod 0.23 MG Oral Capsule [Zeposia]) / 3 (ozanimod 0.46 MG Oral Capsule [Zeposia]) } Pack [Zeposia 7-Day Starter Pack] 93.3% PA